Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clarivate (CLVT) Cash & Equivalents (2017 - 2025)

Clarivate (CLVT) has disclosed Cash & Equivalents for 9 consecutive years, with $329.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 11.52% year-over-year to $329.2 million, compared with a TTM value of $329.2 million through Dec 2025, up 11.52%, and an annual FY2025 reading of $329.2 million, up 11.52% over the prior year.
  • Cash & Equivalents was $329.2 million for Q4 2025 at Clarivate, up from $318.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $2.6 billion in Q2 2021 and bottomed at $295.2 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $594.4 million, with a median of $373.6 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents surged 320.63% in 2021, then plummeted 85.95% in 2022.
  • Year by year, Cash & Equivalents stood at $430.9 million in 2021, then decreased by 17.2% to $356.8 million in 2022, then rose by 3.9% to $370.7 million in 2023, then decreased by 20.37% to $295.2 million in 2024, then rose by 11.52% to $329.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for CLVT at $329.2 million in Q4 2025, $318.7 million in Q3 2025, and $362.6 million in Q2 2025.